|Bid||1,291.20 x 0|
|Ask||1,291.60 x 0|
|Day's range||1,284.00 - 1,305.20|
|52-week range||1,284.00 - 1,857.00|
|Beta (5Y monthly)||0.34|
|PE ratio (TTM)||10.23|
|Earnings date||28 Oct 2020|
|Forward dividend & yield||0.76 (5.83%)|
|Ex-dividend date||12 Nov 2020|
|1y target est||1,644.50|
GlaxoSmithKline plc (LON:GSK) shareholders are probably feeling a little disappointed, since its shares fell 3.9% to...
Eli Lilly (LLY), Merck (MRK), Pfizer (PFE), Novartis (NVS) and others release Q3 results
The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.